Homocysteine levels and Parkinson's disease symptoms
Part of Brain & nervous system clinical trials.
This study looks at whether a substance in your blood called homocysteine is linked to how Parkinson's disease affects you. It might help doctors understand the disease better and could guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have been diagnosed with Parkinson's disease.
- Your Parkinson's is not caused by an infection, medication, poisoning, stroke, or head injury.
- You do not have another brain condition like multiple system atrophy, progressive supranuclear palsy, or dementia with Lewy bodies.
- You did not have significant memory problems before your Parkinson's symptoms started.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether controlling homocysteine levels can help people with Parkinson's disease who are taking levodopa. You may qualify if you take at least 300 mg of levodopa per day, are between 40 and 90 years old, and have no major kidney problems or uncontrolled high blood pressure.
This study measures blood biomarkers (measurable substances in blood) in people with Parkinson’s at different stages. It may help doctors understand how Parkinson’s changes over time and could guide future testing or treatments.
This study is testing whether a simple blood test can help doctors better understand Parkinson's disease by looking at how a protein called alpha-synuclein behaves. It aims to find a new way to diagnose and track the disease.
This study examines changes in alpha-synuclein, a protein linked to Parkinson's, to better understand how the disease progresses. It may help researchers learn more about Parkinson's and improve future care.
This study looks for new markers in the blood or other samples to help diagnose Parkinson's disease earlier. It compares people with Parkinson's, related conditions (like multiple system atrophy or progressive supranuclear palsy), and healthy volunteers to find differences.
This trial tests if taking daily amino acid supplements helps people with Parkinson's disease. You need to be on stable Parkinson's medication for at least 3 months.
Hear when a new Parkinson's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.